background
rotaviru
rv
main
caus
sever
gastroenter
children
effect
vaccin
regim
rv
substanti
reduc
morbid
mortal
previou
studi
demonstr
efficaci
viruslik
particl
form
rv
well
recombin
adenoviru
express
rv
rad
elicit
protect
immun
rv
howev
efficaci
primeboost
strategi
incorpor
vlp
rad
induc
protect
immun
rv
address
assess
immun
effect
differ
regimen
mice
includ
rad
boost
radvlp
primerad
boost
vlprad
rad
alon
vlp
alon
result
mice
immun
vlprad
regimen
elicit
stronger
humor
mucos
cellular
immun
respons
immun
regimen
rv
challeng
experi
show
highest
reduct
viral
shed
achiev
vlprad
group
compar
radvlp
vlp
alon
rad
alon
treatment
group
reduct
rv
shed
mice
correl
fecal
igg
r
p
iga
r
p
conclus
primerad
boost
regimen
effect
confer
immunoprotect
rv
challeng
mice
find
may
lay
groundwork
altern
strategi
novel
rv
vaccin
develop
author
contribut
hz
lg
mw
construct
character
immun
mice
evalu
immun
respons
jq
character
electron
microscopi
hz
zz
jw
wrote
manuscript
zz
zhou
et
al
rotaviru
rv
infect
common
caus
sever
gastroenter
children
rvinduc
gastroenter
respons
death
children
everi
year
death
occur
develop
countri
nearli
two
million
children
hospit
annual
due
rv
infect
us
food
drug
administr
fda
licens
first
rv
vaccin
howev
vaccin
withdrawn
one
year
later
due
common
side
effect
intussuscept
recent
year
two
live
rv
vaccin
attenu
human
rv
strain
develop
glaxosmithklin
pentaval
humanbovin
reassort
develop
merck
licens
sever
countri
yet
protect
mechan
rv
vaccin
fulli
understood
previou
studi
shown
rv
interact
larg
fraction
human
naiv
b
cell
immun
use
protein
dna
induc
protect
immun
mice
gnotobiot
pig
anim
model
also
shown
doubl
layer
viruslik
particl
vlp
form
rv
togeth
mucos
adjuv
abl
induc
protect
immun
studi
strongli
suggest
play
key
role
rv
protect
immun
recombin
adenovirus
rad
wide
use
develop
viral
vaccin
due
safeti
effect
gene
transfer
express
administr
rad
express
human
rv
oral
intranas
stimul
effect
specif
humor
mucos
cellular
immun
respons
confer
protect
rv
infect
mice
studi
also
shown
combin
rad
dna
protein
primeboost
strategi
effect
enhanc
immun
respons
target
antigen
method
appli
develop
vaccin
hiv
mani
virus
present
studi
investig
efficaci
primeboost
regimen
elicit
specif
protect
immun
rv
infect
mice
found
mice
immun
primerad
boost
regimen
elicit
stronger
humor
mucos
cellular
immun
respons
confer
stronger
protect
rv
challeng
immun
regimen
data
suggest
use
vlp
primerad
boost
strategi
develop
effect
rv
vaccin
ass
effect
differ
vaccin
regimen
elicit
specif
humor
respons
mice
figur
serum
igg
iga
target
rv
analyz
indirect
elisa
found
first
immun
day
postinocul
igg
present
mice
subject
vlprad
vlp
treatment
moreov
third
immun
dpi
igg
antibodi
level
vlprad
group
gmt
vlp
group
gmt
significantli
higher
two
group
vlprad
group
vs
radvlp
group
gmt
p
vlp
rad
group
vs
rad
group
gmt
p
vlp
group
vs
rad
vlp
group
p
vlp
group
vs
rad
group
p
igg
present
mice
radvlp
group
third
immun
rad
group
seroconvers
observ
mice
figur
iga
detect
group
howev
antibodi
appear
dpi
dpi
mice
immun
vlprad
vlp
figur
iga
level
vlp
rad
group
highest
dpi
mice
group
posit
iga
dpi
serum
iga
vlprad
group
gmt
significantli
higher
vlp
group
gmt
p
vlp
group
mice
show
iga
posit
dpi
serum
iga
radvlp
group
rad
alon
group
remain
neg
durat
studi
figur
result
demonstr
among
four
strategi
test
boost
strategi
effect
induc
humor
immun
respons
rv
mice
assess
abil
variou
immun
regimen
induc
specif
mucos
antibodi
respons
determin
level
rv
specif
igg
figur
iga
figur
fecal
matter
fecal
suspens
measur
third
immun
result
show
dpi
iga
igg
neg
experiment
control
group
second
immun
iga
vlprad
group
vlp
group
increas
increas
igg
respect
dpi
iga
vlprad
group
vlp
group
increas
igg
increas
respect
signific
differ
fecal
iga
p
igg
p
level
two
group
notabl
iga
igg
pb
radvlp
rad
group
neg
inocul
vlprad
group
mice
test
posit
iga
dpi
mice
posit
dpi
contrast
vlp
treat
group
mice
test
iga
posit
dpi
furthermor
vlp
treat
mice
test
posit
presenc
igg
fecal
matter
dpi
wherea
mice
vlprad
group
posit
dpi
dpi
result
indic
vlprad
regimen
effect
regimen
test
elicit
mucos
immun
respons
secret
cytokin
analyz
cba
technolog
profil
cellular
immun
respons
differ
vaccin
regimen
figur
found
level
cytokin
cytokin
increas
follow
immun
scheme
although
detect
statist
differ
level
specif
cytokin
mice
vlprad
radvlp
group
exhibit
higher
cytokin
level
overal
tnf
secret
vlp
group
tnf
pgml
pgml
pgml
pgml
pgml
nearli
determin
protect
confer
boost
boost
well
alon
five
mice
group
challeng
murin
rv
edim
dpi
viral
shed
curv
figur
indic
mice
pb
group
shed
viru
earli
day
challeng
viral
shed
experiment
group
decreas
variou
degre
challeng
reduct
shed
figur
vlprad
group
highest
reduct
mous
reduct
shed
vlp
group
radvlp
group
rad
group
respect
number
lower
vlprad
group
vari
larg
among
individu
group
result
suggest
boost
regimen
effect
regimen
confer
immunoprotect
rv
challeng
mice
present
studi
compar
effect
vlp
primerad
boost
rad
primevlp
boost
regimen
elicit
antirv
protect
immun
result
demonstr
boost
regimen
effect
stimul
specif
immun
confer
higher
protect
regimen
test
administ
mice
via
intranas
rout
elicit
vigor
mucos
immun
contrast
administ
via
oral
rout
ensur
safeti
use
adenoviru
compon
vaccin
studi
shown
immun
respons
elicit
oral
rad
administr
poor
even
larg
dose
use
rel
small
dosag
adenoviru
immun
ifu
dosag
approxim
document
dose
found
immun
respons
induc
rad
alon
similar
pb
group
indic
rad
alon
unabl
protect
mice
rv
challeng
repeat
immun
effect
induc
humor
mucos
immun
induct
cellular
immun
effect
primeboost
regimen
vlprad
radvlp
rv
challeng
mice
immun
vlp
alon
still
show
obviou
viru
shed
larg
variat
shed
amount
individu
within
group
contrast
vlprad
group
elicit
high
level
humor
mucos
cellular
immun
also
protect
rv
challeng
effect
reduc
amount
viru
shed
vlp
prime
boost
twice
rad
small
dosag
effect
econom
immun
scheme
result
indic
primeboost
regimen
may
synerget
immun
effect
studi
mice
immun
vlprad
regimen
elicit
stronger
humor
mucos
cellular
immun
respons
immun
regimen
reason
dispar
unclear
one
possibl
explan
may
differ
induc
innat
immun
rad
vlp
lead
differ
type
strength
adapt
immun
respons
vlp
rad
recogn
differ
pattern
recognit
receptor
tolllik
receptor
may
lead
differ
cytokin
activ
sequenc
primeboost
immun
may
also
affect
cytokin
milieu
milieu
may
determin
final
direct
strength
breadth
variou
adapt
immun
includ
balanc
immun
respons
differ
mechan
howev
mechan
unravel
data
alon
system
biolog
approach
analyz
marker
immun
respons
differ
primeboost
regimen
may
need
although
molecular
mechan
regul
immunoprotect
rv
still
unclear
immunolog
indic
accur
reflect
protect
rv
infect
remain
establish
mucos
immun
appear
import
antirv
protect
immun
correl
analysi
variou
immun
indic
reduct
rv
shed
mice
indic
reduct
shed
depend
level
fecal
igg
antibodi
r
p
iga
antibodi
r
p
see
tabl
find
suggest
protect
rv
correl
local
intestin
mucos
immun
observ
consist
find
immun
evok
mainli
present
intestin
sever
studi
suggest
cellular
immun
play
import
role
clearanc
rv
infect
howev
although
radvlp
regimen
induc
strong
cell
respons
observ
correl
reaction
protect
efficaci
futur
studi
multipl
method
epitop
may
necessari
determin
cellular
immun
respons
precis
assess
signific
antirv
immun
studi
shown
boost
regimen
elicit
protect
immun
rv
infect
superior
regimen
boost
alon
alon
thu
boost
regimen
may
provid
altern
strategi
novel
rv
vaccin
develop
recombin
replic
defect
adenoviru
serotyp
express
rv
term
gener
adeasi
system
stratagen
cedar
creek
tx
follow
manufactur
instruct
express
confirm
western
blot
analysi
use
antibodi
rv
biodesign
cat
viru
titer
adenox
rapid
titer
kit
bd
bioscienc
clontech
mountain
view
ca
store
prior
use
produc
express
rv
simultan
spodoptera
frugiperda
cell
recombin
baculoviru
recombin
baculoviru
gener
bactobac
baculoviru
express
system
invitrogen
carlsbad
ca
accord
manufactur
protocol
rv
purifi
ultracentrifug
describ
previous
briefli
supernat
cell
infect
recombin
baculoviru
collect
day
post
infect
cellular
debri
remov
centrifug
min
rpm
precipit
final
concentr
clarifi
supernat
precipit
pellet
sonic
briefli
follow
ultracentrifug
rpm
hour
sucros
cushion
presenc
purifi
confirm
western
blot
use
antirv
antibodi
concentr
verifi
electron
microscopi
concentr
purifi
protein
determin
use
bca
protein
assay
reagent
kit
pierc
rockford
il
protein
store
prior
use
sixto
eightweek
old
femal
balbc
mice
obtain
institut
laboratori
anim
scienc
chines
academi
medic
scienc
maintain
anim
biosafeti
facil
mice
confirm
rv
antibodyfre
elisa
prior
immun
random
one
five
treatment
group
shown
figur
vlp
group
mice
intranas
inocul
rv
day
respect
vlprad
group
mice
prime
rv
day
follow
twice
oral
boost
ifu
infecti
unit
ml
dose
day
respect
radvlp
group
mice
oral
prime
ifu
ml
dose
day
follow
twice
boost
rv
day
rad
group
mice
oral
day
postinocul
dpi
serum
stool
sampl
collect
mous
immun
sera
store
analysi
five
mice
group
euthan
dpi
splenocyt
isol
cytokin
measur
remain
five
mice
group
challeng
diarrheainduc
dose
murin
edim
rv
dpi
stool
sampl
collect
daili
dpi
fece
weigh
resuspend
pb
ph
wtvol
debri
remov
centrifug
supernat
store
analysi
ninetysixwel
polystyren
microtit
plate
costar
bethesda
md
coat
overnight
antigen
dilut
carbon
buffer
optim
experi
well
wash
three
time
volvol
tween
pb
pbst
block
bsa
sigma
st
loui
mo
pb
pbsbsa
hour
wash
serum
stool
homogen
dilut
pbsbsa
ad
plate
incub
hour
prevent
nonspecif
bind
subsequ
plate
wash
incub
hour
horseradish
peroxidas
hrp
label
antimous
immunoglobulin
g
igg
iga
sigma
st
loui
mo
dilut
pbsbsa
color
develop
ad
sure
blue
tmb
sigma
st
loui
mo
peroxidas
substrat
absorb
read
nm
use
biorad
elisa
plate
reader
biorad
hercul
ca
serum
twofold
serial
dilut
determin
antibodi
titer
presenc
rv
antigen
fecal
sampl
determin
sandwichelisa
use
rotaviru
assay
kit
lanzhou
institut
biolog
product
lanzhou
china
accord
manufactur
protocol
individu
stool
sampl
wtvol
specimen
determin
use
elisa
plate
reader
biorad
hercul
ca
viral
shed
curv
anim
plot
area
curv
anim
calcul
reduct
shed
calcul
immun
anim
compar
area
curv
mean
area
curv
control
group
reduct
shed
calcul
vaccin
group
determin
mean
reduct
vaccin
group
reduct
viru
shed
individu
anim
group
consid
signific
protect
viru
challeng
freshli
isol
murin
splenocyt
cultur
roundbottom
tissu
cultur
plate
cellswel
complet
rpmi
medium
invitrogen
carlsbad
ca
cell
stimul
peptid
rlsfqlmrppnmtp
synthes
chines
academi
militari
medic
scienc
hour
supernat
collect
secret
quantifi
use
mous
cytokin
cytometr
array
bead
cba
kit
bd
pharmingen
san
diego
ca
accord
manufactur
protocol
secret
detect
facscalibur
flow
cytomet
bd
bioscienc
san
jose
ca
use
twocolor
detect
analyz
use
cba
softwar
bd
pharmingen
antibodi
titer
express
geometr
mean
titer
gmt
rvspecif
antibodi
detect
valu
onehalf
lowest
detect
level
assign
sampl
use
calcul
mean
standard
error
valu
sampl
two
time
background
consid
posit
differ
group
compar
student
ttest
correl
analysi
perform
pearson
correl
test
twotail
p
valu
consid
signific
